Rejdak, K., Leary, S. M., Nelissen, I., Opdenakker, G., Dubois, B., Thompson, A. J., & Giovannoni, G. (2004). Urinary neopterin is a sensitive marker of longitudinal interferon beta-1a treatment in primary progressive multiple sclerosis patients. European Journal of Neurology, 11, 120. (Original work published 2004)